HDAC9 and atherosclerosis: Changes in HDAC expression and the use of HDAC inhibitors have also been suggested as modulating the progression of atherosclerosis and other vascular diseases by regulating macrophage cholesterol efflux and vascular smooth muscle cell proliferation (28, 29).